{"key":"pnc-27","slug":"pnc-27","name":"PNC-27","other_names":[],"kind":"single","area":{"slug":"other","name":"Other"},"classification":"p53-derived peptide","standing":{"id":"preclinical","label":"Animal and cell studies","rank":1},"summary":"A peptide containing part of the p53 protein's MDM2-binding region, studied against cancer cells in the laboratory.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":23,"in_humans":17,"clinical_trials":0},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/pnc-27","article":null,"evidence":{"query":"(\"PNC-27\"[tiab])","fetched_at":"2026-11-16T23:05:32.448Z","counts":{"rcts":0,"human":17,"total":23,"reviews":2,"clinicalTrials":0},"years":[{"year":2012,"count":0},{"year":2013,"count":0},{"year":2014,"count":1},{"year":2015,"count":1},{"year":2016,"count":1},{"year":2017,"count":1},{"year":2018,"count":1},{"year":2019,"count":1},{"year":2020,"count":3},{"year":2021,"count":1},{"year":2022,"count":2},{"year":2023,"count":2},{"year":2024,"count":2},{"year":2025,"count":1},{"year":2026,"count":0}],"top":[{"doi":"10.22038/IJBMS.2022.65590.14430","url":"https://pubmed.ncbi.nlm.nih.gov/36311203/","kind":"study","pmid":"36311203","year":2022,"title":"Conjugated PNC-27 peptide/PEI-superparamagnetic iron oxide nanoparticles (SPIONs) as a double targeting agent for early cancer diagnosis: In vitro study","venue":"Iranian journal of basic medical sciences","authors":"Rahmani R, Darroudi M, Gharanfoli M, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/40750238/","kind":"study","pmid":"40750238","year":2025,"title":"HDM-2-Targeting Peptide PNC-27 Kills Cervical Cancer Cells but not Normal Cervical Cells","venue":"Annals of clinical and laboratory science","authors":"Krzesaj PK, Seydafkan S, Miller AI, et al."},{"doi":"10.3390/biomedicines10050945","url":"https://pubmed.ncbi.nlm.nih.gov/35625682/","kind":"study","pmid":"35625682","year":2022,"title":"PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis","venue":"Biomedicines","authors":"Sarafraz-Yazdi E, Mumin S, Cheung D, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/38802154/","kind":"study","pmid":"38802154","year":2024,"title":"Anti-Cancer Peptide PNC-27 Kills Cancer Cells by Unique Interactions with Plasma Membrane-Bound hdm-2 and with Mitochondrial Membranes Causing Mitochondrial Disruption","venue":"Annals of clinical and laboratory science","authors":"Krzesaj P, Adler V, Feinman RD, et al."},{"doi":"10.3390/biomedicines12061144","url":"https://pubmed.ncbi.nlm.nih.gov/38927351/","kind":"review","pmid":"38927351","year":2024,"title":"Poptosis or Peptide-Induced Transmembrane Pore Formation: A Novel Way to Kill Cancer Cells without Affecting Normal Cells","venue":"Biomedicines","authors":"Pincus MR, Silberstein M, Zohar N, et al."},{"doi":"10.2174/138161211797416075","url":"https://pubmed.ncbi.nlm.nih.gov/21728981/","kind":"review","pmid":"21728981","year":2011,"title":"Anti-cancer peptides from ras-p21 and p53 proteins","venue":"Current pharmaceutical design","authors":"Pincus MR, Fenelus M, Sarafraz-Yazdi E, et al."}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}